Data / Drug companies / R.L.Fine Chem Private Limited
R.L.Fine Chem Private Limited: 34 products in the FDA NDC directory, labeler code 71554
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
R.L.Fine Chem Private Limited (labeler code 71554) lists 34 products in the FDA National Drug Code Directory. By type: 34 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 13, 2026.
The request: Watch R.L.Fine Chem Private Limited (FDA labeler code 71554): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71554
- Products in commercial distribution
- 34
- Packages
- 121
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 7
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- April 25, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 97.1% |
| Bulk ingredients for compounding | 1 | 2.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 34 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 34 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Calcium gluconate | 71554-124 | Powder | Bulk ingredients | May 13, 2026 |
| Tolnaftate | 71554-123 | Powder | Bulk ingredients | February 4, 2026 |
| Tolnaftate | 71554-122 | Powder | Bulk ingredients | February 4, 2026 |
| Carbinoxamine maleate | 71554-121 | Powder | Bulk ingredients | October 1, 2025 |
| Oxazepam | 71554-120 | Powder | Bulk ingredients | April 28, 2025 |
| Temazepam | 71554-029 | Powder | Bulk ingredients | October 19, 2023 |
| Pyrimethamine | 71554-028 | Powder | Bulk ingredients | August 27, 2022 |
| Fluphenazine hydrochloride | 71554-027 | Powder | Bulk ingredients | August 22, 2022 |
| Metyrosine | 71554-026 | Powder | Bulk ingredients | December 30, 2021 |
| Clozapine | 71554-025 | Powder | Bulk ingredients | January 8, 2021 |
| Clomipramine hydrochloride | 71554-024 | Powder | Bulk ingredients | January 8, 2021 |
| Desvenlafaxine succinate monohydrate | 71554-023 | Powder | Bulk ingredients | October 23, 2020 |
| Trihexyphenidyl hydrochloride | 71554-022 | Powder | Bulk ingredients | October 23, 2020 |
| Clonazepam | 71554-021 | Powder | Bulk ingredients | October 23, 2020 |
| Pyrimethamine | 71554-020 | Powder | Bulk ingredients | October 23, 2020 |
| Pramoxine hydrochloride | 71554-119 | Powder | Bulk ingredients | August 25, 2020 |
| Diazepam | 71554-118 | Powder | Bulk ingredients for compounding | August 11, 2020 |
| Trimeprazine tartrate | 71554-117 | Powder | Bulk ingredients | May 25, 2020 |
| Cyclobenzaprine hydrochloride | 71554-116 | Powder | Bulk ingredients | May 18, 2020 |
| Duloxetine hydrochloride | 71554-015 | Powder | Bulk ingredients | May 13, 2019 |
| Chlordiazepoxide | 71554-014 | Powder | Bulk ingredients | May 13, 2019 |
| Alprazolam | 71554-013 | Powder | Bulk ingredients | May 13, 2019 |
| Orphenadrine citrate | 71554-012 | Powder | Bulk ingredients | April 27, 2019 |
| Nortriptyline hydrochloride | 71554-011 | Powder | Bulk ingredients | April 27, 2019 |
| Meclizine | 71554-010 | Powder | Bulk ingredients | April 27, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.